Solution structure of the complex between poxvirus-encoded CC chemokine inhibitor vCCI and human MIP-1β

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 38, 2006, Pages 13985-13990

  Zhang, Li ^a   DeRider, Michele ^a,d   McCornack, Melissa A ^a,e   Jao, Shu Chuan ^a,f   Isern, Nancy ^b   Ness, Traci ^c,g   Moyer, Richard ^c   LiWang, Patricia J ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d Cardinal Health   (United States)

^e PROMEGA CORPORATION   (United States)

^f ACADEMIA SINICA   (Taiwan)

^g UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Chemokine binding protein; Inflammation; NMR; Protein:protein complex

Indexed keywords

BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR ANTAGONIST; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROTEIN VCCI; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BETA SHEET; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE ACTIVATION; NONHUMAN; ORTHOPOXVIRUS; POXVIRUS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN STRUCTURE; STOICHIOMETRY;

AMINO ACID SEQUENCE; ANIMALS; CHEMOKINE CCL4; CHEMOKINES, CC; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MULTIPROTEIN COMPLEXES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; POXVIRIDAE; PROTEIN BINDING; PROTEIN CONFORMATION; RABBITS; SEQUENCE ALIGNMENT; VIRAL PROTEINS; VIRULENCE FACTORS;

ORTHOPOXVIRUS; POXVIRIDAE;

EID: 33749011677     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0602142103     Document Type: Article

References (45)

1. Baggiolini, M (2001) J Int Med 250:91-104.
2. Gerard C, Rollins BJ (2001) Nat Immunol 2:108-115.
3. Clore GM, Appella E, Yamada M, Matsushima K, Gronenborn AM (1990) Biochemistry 29:1689-1696.
4. Mayer KL, Stone MJ (2000) Biochemistry 39:8382-8395.
5. Crump MP, Gong J-H, Loetscher P, Rajarathnam K, Amara A, Arenzana-Seisdedos F, Virelizier J-L, Baggiolini M, Sykes B, Clark-Lewis I (1997) EMBO J 16:6996-7007.
6. Fernandez EJ, Lolis E (2002) Annu Rev Pharmacol Toxicol 42:469-499.
7. Lodi PJ, Garrett DS, Kuszewski J, Tsang ML-S, Weatherbee JA, Leonard WJ, Gronenborn AM, Clore GM (1994) Science 263:1762-1767.
8. Laurence JS, Blanpain C, Parmentier M, Burgner JW, LiWang PJ (2000) Biochemistry 39:3401-3409.
9. Proudfoot AE, Handel TM, Johnson Z, Lau EK, LiWang P, Clark-Lewis I, Borlat F, Wells TN, Kosco-Vilbois MH (2003) Proc Natl Acad Sci USA 100:1885-1890.
10. Lau EK, Allen S, Hsu AR, Handel TM (2004) Adv Protein Chem 68:351-391.
11. McCornack MA, Cassidy CK, LiWang PJ (2003) J Biol Chem 278:1946-1956.
12. Shaw JP, Johnson Z, Borlat F, Zwahlen C, Kungl A, Roulin K, Harrenga A, Wells TN, Proudfoot AE (2004) Structure (London) 12:2081-2093.
13. Alexander JM, Nelson CA, van Berkel V, Lau EK, Studts JM, Brett TJ, Speck SH, Handel TM, Virgin HW, Fremont DH (2002) Cell 111:343-356.
14. Skelton NJ, Quan C, Reilly D, Lowman H (1999) Structure (London) 7:157-168.
15. Boomker JM, de Leij LF, The TH, Harmsen MC (2005) Cytokine Growth Factor Rev 16:91-103.
16. Seet BT, McFadden G (2002) J Leukoc Biol 72:24-34.
17. Lalani AS, Ness TL, Singh JK, Harrison JK, Seet BT, Kelvin DJ, McFadden G, Moyer RW (1998) Virology 250:173-184.
18. Dabbagh K, Xiao Y, Smith C, Stepick-Biek P, Kim SG, Lamm WJ, Liggitt DH, Lewis DB (2000) J Immunol 165:3418-3422.
19. Carfi A, Smith CA, Smolak PJ, McGrew J, Wiley DC (1999) Proc Natl Acad Sci USA 96:12379-12383.
20. Laurence JS, Blanpain C, De Leener A, Parmentier M, LiWang PJ (2001) Biochemistry 40:4990-4999.
21. DeRider ML, Zhang L, LiWang PJ (2006) J Biomol NMR, 10.1007/S10858-005- 6276-x (lett).
22. Zhang L, LiWang P (2006) J Biomol NMR, 10.1007/s10858-006-9021-1 (lett).
23. Wishart DS, Sykes BD (1994) Methods Enzymol 239:363-393.
24. Muhandiram DR, Xu GY, Kay LE (1993) J Biomol NMR 3:463-470.
25. Alcami A, Symons JA, Collins PD, Williams TJ, Smith GL (1998) J Immunol 160:624-633.
26. Burns JM, Dairaghi DJ, Deitz M, Tsang M, Schall TJ (2002) J Biol Chem 277:2785-2789.
27. Beck CG, Studer C, Zuber JF, Demange BJ, Manning U, Urfer R (2001) J Biol Chem 276:43270-43276.
28. Seet BT, Singh R, Paavola C, Lau EK, Handel TM, McFadden G (2001) Proc Natl Acad Sci USA 98:9008-9013.
29. Koopmann W, Ediriwickrema C, Krangel MS (1999) J Immunol 163:2120-2127.
30. Lalani AS, Graham K, Mossman K, Rajarathnam K, Clark-Lewis I, Kelvin D, McFadden G (1997) J Virol 71:4356-4363.
31. Webb LM, Smith VP, Alcami A (2004) FASEB J 18:571-573.
32. Morgan WD, Kragt A, Feeney J (2000) J Biomol NMR 17:337-347.
33. Delaglio F, Grzesiek S, Vuister GW, Hu G, Pfeifer J, Bax A (1995) J Biomol NMR 6:277-293.
34. Yamazaki T, Lee W, Arrowsmith CH, Muhandiram DR, Kay LE (1994) J Am Chem Soc 116:11655-11666.
35. Grzesiek S, Bax A, Clore GM, Gronenborn AM, Hu JS, Kaufman J, Palmer I, Stahl SJ, Wingfield PT (1996) Nat Struct Biol 3:340-345.
36. Zhang O, Forman-Kay JD, Shortle D, Kay LE (1997) J Biomol NMR 9:181-200.
37. Kay LE, Torchia DA, Bax A (1989) Biochemistry 28:8972-8979.
38. Chou JJ, Gaemers S, Howder B, Louis JM, Bax A (2001) J Biomol NMR 21:377-382.
39. Mohana-Borges R, Goto NK, Kroon GJA, Dyson HJ, Wright PE (2004) J Mol Biol 340:1131-1142.
40. Hall JB, Dayie KT, Fushman D (2003) J Biomol NMR 26:181-186.
41. Bax A (2003) Protein Sci 12:1-16.
42. Cornilescu G, Delaglio F, Bax A (1999) J Biomol NMR 13:289-302.
43. Fiser A, Do RK, Sali A (2000) Protein Sci 9:1753-1773.
44. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) J Comput Chem 25:1605-1612.
45. Delaglio F, Kuszewski J (2004) DYNAMO: A Structure Calculation and Analysis Program (National Institutes of Health, Bethesda).